about
Immunobiology of hepatocarcinogenesis: Ways to go or almost there?Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinomaHepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagySmad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseasesTurning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives.Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesisMolecular classification and novel targets in hepatocellular carcinoma: recent advancementsPhase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-FluorouracilThe risk of HCV infection among health-care workers and its association with extrahepatic manifestations (Review).Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patientsHepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.Genetic polymorphism of the human organic solute carrier protein 1 (hOSCP1) gene in Japanese patients with non-viral liver carcinoma.Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populationsRole of lipid rafts in liver health and diseaseHepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.Hepatocellular carcinoma in Asia: Prevention strategy and planning.The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction.miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin.A tailored health surveillance program unveils a case of MALT lymphoma in an HCV-positive health-care workerTreatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantationHepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells.Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular CarcinomaNon-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy.Immunobiology of hepatocellular carcinoma.Lipoprotein receptors and lipid enzymes in hepatitis C virus entry and early steps of infection.Hepatitis B and C viruses and hepatocellular carcinoma.(Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression.TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target.Delivery strategies and potential targets for siRNA in major cancer typesRedox proteomics screening cellular factors associated with oxidative stress in hepatocarcinogenesis.Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteinsModulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase.HCV core inhibits hepatocellular carcinoma cell replicative senescence through downregulating microRNA-138 expression.Hepatitis C virus core protein increases Snail expression and induces epithelial-mesenchymal transition through the signal transducer and activator of transcription 3 pathway in hepatoma cells.Promotion of hepatocellular carcinoma by hepatitis C virus.Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients: results from the DANVIR cohort study.Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C.A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.
P2860
Q26738293-C2C6DECC-F0F9-4817-A067-FA6D2128BADEQ26773251-1C6DE950-6BDB-4120-B90F-D58AAD9FCCF9Q26801207-2CAEC51D-6DAB-4DF2-9633-11A3447509CEQ26863522-268C5CF5-2B39-4557-B3A8-A40C2C68F19AQ27692697-E7C5FEDA-7179-4837-9773-A1D44B5CC18FQ28075646-84B220DE-EC32-473F-8C4C-8B2ECDEEAA5CQ28383646-C5653870-26EB-416B-B3EB-AB35C6613A8BQ33428936-DC01A9CC-5207-4AE0-BADD-9F17389DE656Q33673394-C50E560D-D964-44B4-A431-BC50A942B7CBQ33786041-84D8A9A5-4F36-4ACB-A406-4A538F031C37Q34765478-1510AF34-C360-4F5A-9E1B-91C36BF6F0E9Q34878913-888FC8E7-2FEF-41C3-839D-189E19F06CE0Q34918154-7E7DBB41-3441-4395-B958-A2DE812993BCQ35012726-20C7D98B-1F37-4BC6-BFCA-763ED7DF5431Q35531664-18A15B64-403D-4C13-A64A-6A10D9A99911Q35555547-A5B7D345-8DAB-425A-894C-3C77F1A4083BQ35790424-BB10FAE9-3A84-49EC-B944-6175EC64D413Q36035557-C957BEF5-CA15-4C9E-9B21-77EDE234D4B7Q36413338-B63E95CC-8550-4909-BF5F-DC507957B393Q36611646-B7517C98-667A-4526-A985-3A621BF79F3DQ36897917-E7E35121-AA23-4BFD-A36C-1252E65AFE5DQ36978634-3F4CA695-8CF3-4FED-A821-ED652D818F07Q37297666-4AAFEB5B-9876-48E5-ADDD-9AB02E01D8C6Q37358612-A6B0D421-28DF-4054-88CD-9219E4B4A2E8Q37491353-F90567BE-54E7-426C-B0AA-DBE3619C9CCCQ37863516-0E7BC307-C5A7-4D15-9ED5-A2A6F17AEFD5Q38166372-24A8BF0E-B5A4-4821-93D7-88A27600D4CDQ38615769-A24CA570-EC5D-4CA7-B73C-F644CCBAD5B7Q38765115-E32347E9-FE0E-4EA2-AEF6-7A81D19C9F23Q38830698-75A2FE59-B83D-455E-811B-B0FF8BCC3518Q38853191-E217466A-147B-454F-9905-B202E097234DQ38986144-6CA0047F-19BB-447A-9741-C012F6087B0AQ39610357-5CC51D29-D53A-4896-88F5-1D3BF6CFDCC2Q39672405-5F9F28AF-D2FD-4EC7-BD9A-6B66C160FDF5Q40309143-F41F4848-AF82-4D94-B864-81CE3CCBBC67Q40665873-9FF60FF5-3D83-4B23-A3C4-964B32E7AED8Q42288500-603D383A-90B4-48DC-87B8-0C5A9306D65EQ43409999-87E66145-92C2-4671-8AE5-EB7097B9E287Q43598881-AF5BECB9-63C7-48EA-B763-5F38F71465EEQ45166388-3F4488F7-A07D-4FEB-B7E9-570B98AA9B81
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis C virus-induced hepatocarcinogenesis.
@en
Hepatitis C virus-induced hepatocarcinogenesis.
@nl
type
label
Hepatitis C virus-induced hepatocarcinogenesis.
@en
Hepatitis C virus-induced hepatocarcinogenesis.
@nl
prefLabel
Hepatitis C virus-induced hepatocarcinogenesis.
@en
Hepatitis C virus-induced hepatocarcinogenesis.
@nl
P1476
Hepatitis C virus-induced hepatocarcinogenesis
@en
P2093
Hubert E Blum
Robert Thimme
P304
P356
10.1016/J.JHEP.2009.05.008
P577
2009-05-23T00:00:00Z